Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3-phosphoglycerate
-
no inhibition of UDP-glucose synthesis
ADP
in the presence of ATP or ADP, the activity decreases to about 60%
alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate
Ca2+
about 40% inhibition
CTP
-
2 mM, 13% inhibition
D-fructose 2,6-bisphosphate
-
no inhibition of UDP-glucose synthesis
D-fructose 6-phosphate
-
-
D-galactose 6-phosphate
-
UDP-glucose pyrophosphorolysis
D-glucose 1-phosphate
-
2 mM, 14% inhibition
D-glucose 6-phosphate
-
2 mM, 18% inhibition
GTP
-
2 mM, 15% inhibition
H2O2
complete loss of activity after 30 min, inactivation is reverted by reduction by cysteine and thioredoxin
hydrogen peroxide
-
inactivation is reversed by reduction with dithiothreitol or thioredoxin
iodoacetamide
-
wild-type: loss of 56% activity after 30 min at 0.1 mM, mutant C123S is not affected
MgUTP
-
wild-type and mutants C123S, H266R, W218, R389H, R422Q, R445H
NAD+
presence of either NAD or NADP results in a decrease of activity to about 80% or 50%, respectively
NADP+
presence of either NAD or NADP results in a decrease of activity to about 80% or 50%, respectively
sodium nitroprusside
complete loss of activity after 30 min, inactivation is reverted by reduction by cysteine and thioredoxin
sucrose
-
54% inhibition at 2%
alpha-D-galactose 1-phosphate
-
-
alpha-D-galactose 1-phosphate
-
no inhibition
alpha-D-galactose 1-phosphate
-
-
alpha-D-galactose 1-phosphate
-
at high concentrations
alpha-D-galactose 1-phosphate
-
competitive
alpha-D-galactose 1-phosphate
-
-
alpha-D-glucose 1-phosphate
-
UDP-glucose pyrophosphorolysis
alpha-D-glucose 1-phosphate
-
product inhibition
alpha-D-glucose 1-phosphate
-
product inhibition
alpha-D-glucose 1-phosphate
-
product inhibition
ATP
in the presence of ATP or ADP, the activity decreases to about 60%
ATP
-
2 mM, 9.3% inhibition
Co2+
-
no effect on liver enzyme form I, 2fold activation of enzyme form from sublingual gland, inhibition of enzyme form from submandibular gland
Co2+
-
in excess of diphosphate-concentration, activates at lower concentrations
Cu2+
complete inhibition
diphosphate
-
product inhibition
diphosphate
Q94B70
with 0.25 mM 57% activity, with 1 mM 11% activity, with 10 mM 1.5% activity
diphosphate
-
possible alternate regulatory mechanism; product inhibition
diphosphate
-
noncompetitive to glucose 1-phosphate and UTP
diphosphate
-
product inhibition
Mg-diphosphate
-
product inhibition
Mg-diphosphate
-
product inhibition
MgUTP2-
-
-
Mn2+
about 40% inhibition
Mn2+
-
in excess of diphosphate-concentration, activates at lower concentrations
Pb2+
complete inhibition
phosphate
-
-
phosphate
-
noncompetitive to glucose 1-phosphate and UTP
UDP
-
-
UDP
UGPase activity is not significantly decreases in A-549 cells treated with 0.0001-0.003 mM UDP. Activity is significantly decreased at 0.005 mM and 0.1 mM UDP treatments. The inhibition of UGPase activity in A549 cells is 28fold higher at 0.1 mM UDP treatment in comparison to 0.005 mM treatment
UDP
significant decrease in UGPase activity is observed at 0.002 mM UDP treatment. At 0.005 mM UDP, threefold inhibition is observed in UGPase activity in comparison to 0.1 mM. Comparative analysis of UDP treatment on blood isolate and reference D39 strain shows that 0.005 mM UDP treatments for 1 hour are effective to reduce the bacterial UGPase activity by half than in its host counterpart. UDP mediates decrease in the virulence of Streptococcus pneumoniae
UDP-D-mannose
-
-
UDP-galactose
-
UDP-glucose pyrophosphorolysis
UDP-galactose
-
14% inhibition at 0.35 mM
UDP-galactose
-
strong inhibition
UDP-galactose
-
competitive
UDP-galacturonic acid
-
48% inhibition at 0.43 m
UDP-galacturonic acid
-
-
UDP-glucose
-
UDP-galactose pyrophosphorolysis or UDP-glucose synthesis
UDP-glucose
-
87% inhibition at 0.08 mM
UDP-glucose
-
competitive to UTP, noncompetitive to glucose 1-phosphate
UDP-glucose
-
product inhibition
UDP-glucose
-
product inhibition
UDP-glucuronic acid
-
56% inhibition at 0.45 mM
UDP-mannose
-
23% inhibition at 0.45 mM
UDP-xylose
-
-
UDP-xylose
-
32% inhibition at 0.36 mM
UTP
-
product inhibition
UTP
-
UDP-glucose pyrophosphorolysis
UTP
-
competitive to UDP-glucose; product inhibition
UTP
-
2 mM, 20% inhibition
Zn2+
about 50% inhibition
Zn2+
about 40% inhibition
additional information
Acetabularia sp.
-
-
-
additional information
structure-activity relationship of the salicylimide derived inhibitors
-
additional information
-
-
-
additional information
-
-
-
additional information
-
no effect of PCMB, iodoacetate, 2-mercaptoethanol or DTT
-
additional information
-
inhibition kinetics for UDP-sugars; little or no inhibition by alpha-D-mannose 1-phosphate, alpha-D-xylose 1-phosphate or alpha-D-glucuronic acid 1-phosphate
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
not inhibitory: Tween-20
-
additional information
-
not inhibitory: Tween-20
-
additional information
-
inhibition kinetics for UDP-sugars
-
additional information
-
product inhibition pattern
-
additional information
not inhibitory: 1 mM 2-oxoglutaric acid, 3-phosphoglyceric acid, and 5-aminolevulinic acid
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-
additional information
-
-
-